The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | N | Nervous system | |
2 | N05 | Psycholeptics | |
3 | N05B | Anxiolytics | |
4 | N05BA | Benzodiazepine derivatives |
Code | Title | |
---|---|---|
N05BA01 | Diazepam | |
N05BA02 | Chlordiazepoxide | |
N05BA03 | Medazepam | |
N05BA04 | Oxazepam | |
N05BA05 | Potassium clorazepate | |
N05BA06 | Lorazepam | |
N05BA07 | Adinazolam | |
N05BA08 | Bromazepam | |
N05BA09 | Clobazam | |
N05BA10 | Ketazolam | |
N05BA11 | Prazepam | |
N05BA12 | Alprazolam | |
N05BA13 | Halazepam | |
N05BA14 | Pinazepam | |
N05BA15 | Camazepam | |
N05BA16 | Nordazepam | |
N05BA17 | Fludiazepam | |
N05BA18 | Ethyl loflazepate | |
N05BA19 | Etizolam | |
N05BA21 | Clotiazepam | |
N05BA22 | Cloxazolam | |
N05BA23 | Tofisopam | |
N05BA24 | ||
N05BA25 | ||
N05BA56 | Lorazepam, combinations |
Active Ingredient | Description | |
---|---|---|
Alprazolam |
Alprazolam, like other benzodiazepines, has a high affinity for the benzodiazepine binding site in the brain. It facilitates the inhibitory neurotransmitter action of gamma-aminobutyric acid, which mediates both pre- and post synaptic inhibition in the central nervous system (CNS). |
|
Bentazepam |
|
|
Bromazepam |
Bromazepam is a pyridylbenzodiazepine compound with anxiolytic properties. |
|
Chlordiazepoxide |
Chlordiazepoxide has anxiolytic and central muscle relaxant properties. It has little autonomic activity. Chlordiazepoxide acts as depressant of the central nervous system producing all levels of CNS depression, from mild sedation to hypnosis, to coma depending on the dose. |
|
Clobazam |
Clobazam is a 1,5-benzodiazepine and the pharmacodynamic activity is qualitatively similar to that of other compounds of the class of Muscle relaxant, Anxiolytic, Sedative, Hypnotic, Anticonvulsant, Amnesic. |
|
Clorazepate |
Clorazepate is a benzodiazepine with anxiolytic, sedative, hypnotic, and anticonvulsant properties. Clorazepate exerts its effect by de-activating the nervous system through potentiation of the inhibitory effect of gamma-aminobutyric acid (GABA) on the GABA-A receptors by binding to a site that is distinct from the GABA binding site. |
|
Clotiazepam |
|
|
Cloxazolam |
|
|
Diazepam |
Diazepam is a psychotropic substance from the class of 1,4-benzodiazepines with marked properties of suppression of tension, agitation and anxiety as well as sedative and hypnotic effects. In addition, diazepam demonstrates muscle relaxant and anticonvulsive properties. It is used in the short-term treatment of anxiety and tension states, as a sedative and premedicant, in the control of muscle spasm and in the management of alcohol withdrawal symptoms. |
|
Ethyl loflazepate |
|
|
Etizolam |
|
|
Fludiazepam |
|
|
Flutazolam |
|
|
Halazepam |
|
|
Ketazolam |
|
|
Lorazepam |
Lorazepam is a benzodiazepine with anxiolytic, sedative and hypnotic properties. |
|
Medazepam |
|
|
Mexazolam |
Mexazolam is a benzodiazepine indicated for the management of anxiety disorder associated or not to psychoneurotic conditions. The exact sites and mode of action have not been fully elucidated, but it appears to be mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), by the stimulation of specific receptors. Both GABA and chloride may enhance the binding to those receptors. |
|
Desmethyldiazepam |
Nordazepam is a 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively. Nordazepam has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety. |
|
Oxazepam |
Oxazepam is a synthetic benzodiazepine derivative with anxiolytic and sedative hypnotic properties. Although the mechanism of action has not been fully elucidated, oxazepam appears to enhance gamma-aminobutyric acid (GABA) receptor affinity for GABA, thereby prolonging synaptic actions of GABA. |
|
Oxazolam |
|
|
Pinazepam |
|
|
Prazepam |
Prazepam is a benzodiazepine derivative and has depressant effects on the central nervous system. Benzodiazepines act at the level of the limbic, thalamic, and hypothalamic regions of the CNS and can produce any level of CNS depression required including sedation, hypnosis, skeletal muscle relaxation, and anticonvulsant activity. |
|
Tofisopam |
Tofisopam is an atypical benzodiazepine derivative. It has an anxiolytic effect, almost not-accompanied by a sedative, muscle relaxant, anticonvulsant action. Tofisopam is a psychovegetative regulator, it eliminates various forms of autonomic disorders. It has a mild stimulating activity. Due to the lack miorelaxant effect tofisopam can also be used in patients with myopathy and myasthenia. |
Title | Information Source | Document Type | |
---|---|---|---|
AKAMON Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
ATIVAN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
BETAPAM Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
CENTRAX Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
DEMETRIN Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
DIASTAT Gel | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
DIAZEMULS Emulsion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
DIAZEPAM Gel | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
DIAZEPAM Rectal solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
DIAZEPAM Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
DIAZEPAM Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
DIAZEPAM Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
DIAZEPAM Uncoated tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
FRISIUM Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
KRATIUM Solution for injection/infusion | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
KRATIUM Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
LEXOTAN Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
LIBRIUM Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
LORANS Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
LORAZEPAM Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
NALION Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
PERIZAM Oral suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
REMEDIUM Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
TAPCLOB Oral suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
TEMELOR Solution for injection | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
TEMELOR Tablet | MPI, EU: SmPC | ||
TRANXENE Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
URBANOL Capsule / Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
VALIUM Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
XANAX Tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ZOLARAM Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |